Related Experiment Video
Updated: Aug 26, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Mutant p53K120R expression enables a partial capacity to modulate metabolism
Paola Monti1, Silvia Ravera2, Andrea Speciale1
1Mutagenesis and Cancer Prevention Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Abstract:
The TP53 tumor suppressor gene is one of the most studied gene in virtue of its ability to prevent cancer development by regulating apoptosis, cell cycle arrest, DNA repair, autophagy and senescence. Furthermore, the modulation of metabolism by P53 is fundamental for tumor suppressor activity. Studies in mouse models showed that mice carrying TP53 mutations affecting the acetylation in the DNA binding domain still retain the ability to transactivate genes involved in metabolism. Noteworthy, mice expressing the triple 3KR or the single K117R mutant do not show early on-set tumor development in contrast to TP53 mice. Interestingly, the mouse K117R mutation corresponds to the human tumor-derived K120R modification, which abrogates P53-dependent activation of apoptosis without affecting growth arrest. In this study, we investigated the property of the human P53 K120R mutant in the regulation of metabolism by analyzing the transcriptional specificity in yeast- and mammalian-based reporter assays, the metabolic phenotype associated to its expression in colon cancer HCT116 cells and the induction of P53 targets and proteins involved in the antioxidant response. These properties were analyzed in comparison to wild type P53 protein, the human triple mutant corresponding to mouse 3KR and the cancer hot-spot R273H mutant. We confirm the selective functionality of P53 K120R mutant, which shows a transcriptional activity on cell cycle arrest but not on apoptotic targets. Interestingly, this mutant shows a partial transactivation activity on p53 response element belonging to the metabolic target TIGAR. Moreover, we observe a significant uncoupling between oxygen consumption and ATP production associated with higher lipid peroxidation level in all P53 mutants carrying cells with respect to wild type P53 expressing cells. Noteworthy, in the absence of a pro-oxidative challenge, cells expressing K120R mutant retain a partial capacity to modulate glucose metabolism, limiting lipid peroxidation with respect to the other P53 mutants carrying cells. Lastly, especially in presence of human 3KR mutant, a high expression of proteins involved in the antioxidant response is found. However, this response does not avoid the increased lipid peroxidation, confirming that only wild type P53 is able to completely counteract the oxidative stress and relative damages.
Insights
The TP53 K120R mutant selectively activates cell cycle arrest genes but not apoptosis, impacting cellular metabolism and antioxidant responses. This mutant partially regulates metabolism, unlike other TP53 mutants, but cannot fully counteract oxidative stress.
Area of Science:
- Molecular Biology
- Cancer Research
- Metabolic Regulation
Background:
- The TP53 tumor suppressor gene is crucial for preventing cancer by regulating apoptosis, cell cycle arrest, and metabolism.
- TP53 mutations are common in cancer, affecting its tumor-suppressive functions.
- Specific TP53 mutations, like K120R, may retain some functions while losing others, particularly regarding apoptosis and metabolism.
Purpose of the Study:
- To investigate the metabolic regulation properties of the human P53 K120R mutant.
- To compare the transcriptional specificity and metabolic phenotype of P53 K120R with wild-type P53 and other mutants (3KR, R273H).
- To analyze the induction of P53 targets and proteins involved in the antioxidant response.
Main Methods:
- Utilized yeast- and mammalian-based reporter assays to assess transcriptional specificity.
- Analyzed the metabolic phenotype in colon cancer HCT116 cells expressing different P53 variants.
- Measured the induction of P53 targets and antioxidant response proteins.
Main Results:
- P53 K120R mutant selectively activates cell cycle arrest genes, not apoptotic targets.
- The K120R mutant exhibits partial transactivation of the metabolic target TIGAR.
- All P53 mutants showed uncoupled oxygen consumption and ATP production, with increased lipid peroxidation compared to wild-type P53.
Conclusions:
- The P53 K120R mutant displays selective functionality, preserving cell cycle arrest activity while losing apoptotic regulation.
- While K120R partially modulates glucose metabolism and limits lipid peroxidation compared to other mutants, it cannot fully counteract oxidative stress.
- Wild-type P53 is essential for completely counteracting oxidative stress and associated damages.
Related Concept Videos
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....

